Sara, Roderick R.

HRN: 28-69-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/26/2026
04/01/2026
IV DRIP
750mg
OD
Infected Wound R Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: